Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)

3.53
BATS BZX Real-Time Price
As of 2:42pm ET
 +0.125 / +3.68%
Today’s Change
3.08
Today|||52-Week Range
9.00
+6.82%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Zynerba Pharmaceuticals Inc have a median target of 8.50, with a high estimate of 9.00 and a low estimate of 4.50. The median estimate represents a +141.13% increase from the last price of 3.53.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Zynerba Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.26
Sales
$0.00
Reporting Date
Mar 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.54%
 
 
 
 
 
 
Growthannually 48.53%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.